tiprankstipranks
OnKure Therapeutics (OKUR)
NASDAQ:OKUR
US Market
OKUR
OnKure Therapeutics
RESEARCH TOOLSreports
Want to see OKUR full AI Analyst Report?

OnKure Therapeutics (OKUR) Income Statement

439 Followers

OnKure Therapeutics Income Statement

Last quarter (Q4 2025), OnKure Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, OnKure Therapeutics's net income was $-13.50M. See OnKure Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -830.00K$ 0.00$ 0.00$ 0.00$ -50.00K
Operating Expenses
$ 62.12M$ 54.39M$ 36.93M$ 29.77M$ 39.77M
Depreciation and Amortization
$ 830.00K$ 662.00K$ 560.00K$ 387.00K$ 50.00K
EBITDA
$ -62.12M$ -51.71M$ -34.75M$ -29.38M$ -39.72M
Operating Income
$ -62.95M$ -54.39M$ -36.93M$ -29.77M$ -39.82M
Other Income/Expenses
$ 3.43M$ 1.71M$ 1.62M$ 254.00K$ 48.00K
Pretax Income
$ -59.52M$ -52.67M$ -35.31M$ -29.51M$ -39.77M
Net Income
$ -59.52M$ -52.67M$ -35.31M$ -29.51M$ -39.77M
Per Share Metrics
Basic EPS
$ -4.40$ -3.95$ -2.65$ -2.21$ -21.92
Diluted EPS
$ -4.40$ -3.95$ -2.65$ -2.21$ -21.92
Weighted Average Shares Outstanding
 13.52M 13.34M 13.34M 13.34M 1.81M
Weighted Average Shares Outstanding (Diluted)
 13.52M 13.34M 13.34M 13.34M 1.81M
Currency in USD

OnKure Therapeutics Earnings and Revenue History